GlobalData analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

AC Immune (ACIU) stock shot up 20% Thursday after the company reported positive data from a Phase 2 study of its drug ...

For the Cook family, supporting Cure Parkinson's is a personal cause as Joyce's son, Will, was close friends with the late Tom Isaacs, one of the founders of the charity. Will is also the former CEO ...

AC Immune SA (ACIU) has released an update. AC Immune SA announced promising interim results from its Phase 2 trial of the ACI-7104.056 ...

Among the symptoms, losing one's sense of smell could be an easily missed early indicator. The University of Auckland ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

Parkinson's disease is the second most common neurodegenerative ... although there are treatments to manage it, there is no known cure.

Oct. 18, 2024 -- The FDA has approved a new injectable treatment for adults with advanced Parkinson’s disease called Vyalev (also known as Produodopa). This new option is designed to help people ...

Nir Giladi from TAU’s Faculty of Medical and Health Sciences and the Tel Aviv Sourasky Medical Center, as well as other researchers from TAU and the University of Haifa. The study was backed by the ...

The researchers note that, "despite the similarities, patients with these diseases have a different prognosis and do not ...

Back in 2013, David Rabotnick, director and founder of Slow-Motion Magic, was diagnosed with Parkinson’s disease. Instead of ...